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Background: Human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2) are delta retroviruses with similar
genetic organization. Although both viruses immortalize T-cells in vitro, they exhibit distinct pathogenic potential
in vivo. To search for possible differences in its expression strategy with respect to HTLV-1, we investigated the
pattern of HTLV-2 expression in infected cell lines and peripheral blood mononuclear cells (PBMCs) from infected
patients using splice site-specific quantitative RT-PCR.
Findings: A novel alternative splice acceptor site for exon 2 was identified; its usage in env transcripts was found to
be subtype-specific. Time-course analysis revealed a two-phase expression kinetics in an infected cell line and in
PBMCs of two of the three patients examined; this pattern was reminiscent of HTLV-1. In addition, the minus-strand
APH2 transcript was mainly detected in the nucleus, a feature that was similar to its HTLV-1 orthologue HBZ. In
contrast to HTLV-1, expression of the mRNA encoding the main regulatory proteins Tax and Rex and that of the
mRNAs encoding the p28 and truncated Rex inhibitors is skewed towards p28/truncated Rex inhibitors in HTLV-2.
Conclusion: Our data suggest a general converging pattern of expression of HTLV-2 and HTLV-1 and highlight
peculiar differences in the expression of regulatory proteins that might influence the pathobiology of these
viruses.Findings
Human T-cell leukemia virus types 1 and 2 (HTLV-1
and HTLV-2) are related deltaretroviruses [1] with simi-
lar genetic organization and expression strategies [2-4].
Both viruses immortalize T-cells in culture and establish
a persistent infection in vivo [5]. However, unlike HTLV-
1, which causes adult T-cell leukemia/lymphoma (ATLL)
and tropical spastic paraparesis/HTLV-1-associated
myelopathy (TSP/HAM), HTLV-2 has not been linked
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reproduction in any medium, provided the orlymphocytes counts was described in HTLV-2-infected
patients [6] and coinfection with HTLV-2 plays an im-
portant role in the progression of HIV-infected patients
to AIDS [7].
Like HTLV-1, HTLV-2 produces plus- and minus-
strand alternatively spliced transcripts that code for vir-
ion components and non-structural proteins, including
Tax and Rex that regulate viral expression at the tran-
scriptional and post-transcriptional levels, respectively
[8,9]. In contrast to HTLV-1, the kinetics of expression
of the individual HTLV-2 transcripts has not been
described so far. To address this point, we employed
splice site-specific quantitative RT-PCR (qRT-PCR) to
measure individual HTLV-2 mRNAs (Figure 1) and
their expression kinetics in chronically infected cell
lines and in peripheral blood mononuclear cells
(PBMCs) obtained from HTLV-2-infected individuals.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Genetic organization, alternative splicing and coding potential of HTLV-2 mRNAs. Structure and coding potential of HTLV-2
alternatively spliced mRNAs. ORFs are indicated by boxes. Splice sites are indicated by numbers and correspond to the Mo-T isolate (GeneBank:
M10060) in which + 1 is the first base of U3 in the 5’ LTR. Gray lines and numbers designate the 5’ end of exon 2iso identified in the present
study. n.d.: the protein coding potential of this transcript has not yet been determined.
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from HTLV-1 [10].
Identification of a novel HTLV-2 splice acceptor-site
We first analyzed the pattern of viral mRNAs in the
HTLV-2-infected cell lines Mo-T (infected with subtype
A) and BJAB-Gu (infected with subtype B). Pilot experi-
ments showed unexpectedly low (almost 3 orders of
magnitude) levels of the env mRNA in BJAB-Gu cells
compared to Mo-T. Further experiments in the BJAB-Gu
cell line using a sense primer located at the 5’ end of
exon 1 and an antisense primer located in exon 2 yielded
the expected 275 bp band and a slightly longer product
(Figure 2A). Sequence analysis of cloned PCR products
indicated that the longer product was generated by usage
of a novel splice acceptor site (termed "2iso") located 30
nucleotides upstream of exon 2 (Figure 2B). In silico ana-
lysis of different HTLV-2 isolates showed that the novel
2iso 3’splice-site (SS) defines a GU-AG type intron with a
consensus “AGgtaagt” sequence at the exon 1-intron
boundary that varied among the isolates (Figure 2C).Quantitative and temporal analysis of HTLV-2 mRNAs in
infected cell lines
We next tested the expression levels of the different
HTLV-2 mRNAs using splice site-specific primer sets
and qRT-PCR (Additional file 1: Table S1), and we calcu-
lated the Normalized Copy Number (NCN) by dividing
the absolute copy number of each transcript by the ab-
solute copy number of the housekeeping gene (GAPDH
or 18S rRNA, see Figures 3 and 4).
Using two splice site-specific primer pairs, we quanti-
fied the levels of the alternative env transcripts [env(1–2)
and env(1-2iso)] from the Mo-T and BJAB-Gu cell lines
and in cells transfected with the HTLV-2A molecular
clone pH6neo (kindly provided by Dr. P. L. Green).
Results showed that the env(1-2iso) mRNA was
expressed at similar levels in both cell lines, while the ca-
nonic env(1–2) transcript was about 100-fold less abun-
dant in BJAB-Gu cells (Figure 3A). Interestingly, the
HTLV-2A molecular clone pH6neo also expressed
mainly env(1–2), suggesting a subtype-specific usage of
the 2 vs. 2iso 3’SS (Figure 3A). While the sequence of the
Figure 2 Identification of a novel HTLV-2 splice acceptor-site. A. Agarose gel electrophoresis of exon 1–2 and exon 1-2iso RT-PCR products.
BJAB-Gu cDNA was amplified using the 6000-Gu forward primer (5’ GGCGGGCTCCTTCAACG 3’) located in the first exon and the 5183-Gu reverse
primer (5’ CCATGGTGTTGGTGGTCT 3’) in the second exon. Amplification yielded the expected 275-bp band and a slightly longer product (lane 1).
No bands were detected in the no template control (NTC, lane 2); lane 3 shows a 1-kbp molecular weight marker (MWM). Cell lines were cultured
at 37°C, 5% CO2, in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, penicillin (100 U/ml) and streptomycin
(100 μg/ml). Cells were lysed in TRIzolW (Invitrogen) and total RNA was extracted and processed as detailed in Additional file 1: Table S1. B.
Sequence alignment of cloned PCR products and identification of a novel splice acceptor site upstream of exon 2. Nucleotides in exon 1 are in
blue and nucleotides in exon 2 are in red. Sequence analysis demonstrated that the 1-2iso junction is generated by splicing to a novel 3’splice-
site (SS) located 30 nucleotides upstream of the exon 2 3'SS. Numbering of the sequence corresponds to that of the Gu isolate (GenBank: ×
89270.1) in which + 1 is the first base of U3 in the 5’ LTR. ▼ indicates nucleotide position in exon 1; Δ indicates nucleotide position in exon 2 or
2iso. C. Sequence alignment of HTLV-2 isolates. DNA sequences containing exon 1 splice donor (5’SS) and exon 2iso or exon 2 splice-acceptor
(3’SS) sites were compared between various HTLV-2 isolates retrieved from GenBank (accession numbers are indicated on the left, subtypes on
the right). Exons and introns are indicated in upper and lower case, respectively. Underlined nucleotides indicate the 5’SS and 3’SS consensus
sequences. The consensus sequence AGgtaagt at the exon 1-intron boundary varies among 2A and 2B subtypes, while the intronic gt 5’SS and
ag 3’SS dinucleotides are invariable. The 3'SS defining exon 2iso is conserved among the different isolates examined.
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the two isolates, the adjacent nucleotides are different
(Figure 2C), suggesting that this could result in a differ-
ent splice site usage in the different isolates. The 1-2iso
splice acceptor site was also used in the context of a
doubly spliced tax/rex(1-2iso-3) mRNA which was read-
ily detected in both cell lines and in the molecular clone
pH6neo (data not shown). Selection of 1-2iso 3'SS as
opposed to the 1–2 3'SS is not predicted to affect the
coding potential of the env (1–2; 1-2iso), tax/rex (1-2-3;
1-2iso-3) or 1-2-B and 1-2iso-B mRNAs, as both 3'SS are
located in the non-coding portion of the transcripts.
Interestingly, the 1-2iso splice site is not unique to only
the BJAB-Gu cell line, as it is efficiently used in the
patients, which are infected with subtype 2B (see next
paragraph).
In the chronically infected cell lines Mo-T and BJAB-
Gu as well as in cells transfected with the pH6neo mo-
lecular clone the most abundant viral mRNA was gag/pol followed by tax/rex(1-2-3), env and p28/trex(1–3)
(Figure 3A); the latter codes for p28 and the truncated
isoforms of Rex (p22/20 and p19/p18). We proposed to
term these truncated isoforms of Rex as “tRex” [11].
Both p28 and tRex may act as latency factors by inhi-
biting the tax/rex mRNA [12] and the Rex protein, re-
spectively [13]. Interestingly, in HTLV-2 tax/rex was
detected at levels comparable to p28/trex [taxrex/trex
(1–3) ratio = 0.5 in pH6neo-transfections; 1.04 in Mo-T;
0.69 in BJAB-Gu]. This is in contrast with HTLV-1,
where tax/rex is much more abundant than the mRNAs
coding for p30Tof and p21Rex, the orthologs of p28 and
tRex, respectively [10]. These data suggest that the ratio
of expression of the tax/rex mRNA vs. the mRNAs en-
coding potential inhibitors is higher in HTLV-1[10]
compared to HTLV-2. The p28 and tRex proteins are
also coded by the less abundant p28/trex(1-B) mRNA.
Transcript 1-2-B, whose protein product has not yet
been identified and is also expressed as 1-2iso-B; the
Figure 3 Quantitative analysis, intracellular compartmentalization and expression kinetics of HTLV-2 mRNAs in infected cell lines.
Normalized copy number (NCN) and Scaled Copy Numbers (SCN) were calculated as described in the text. Housekeeping genes used for
normalization were GAPDH (panels A and B) and 18S rRNA (panels C and D) and in this latter case (panel C) the obtained NCN were multiplied
for 107. A. NCN of viral mRNAs in the HTLV-2-infected cell lines BJAB-Gu (black bars) and Mo-T (red bars) and in cells transfected with the HTLV-
2A molecular clone pH6neo (yellow bars). Cells were harvested at densities ranging from 100,000/ml (transfected cells) to 500,000/ml (infected
cell lines). Shown are mean values of 3 independent experiments and standard error bars. B. Nucleo-cytoplasmic distribution (NUC/CYT) of plus-
and minus-strand HTLV-2 mRNAs in infected cell lines Mo-T (red bars) and BJAB-Gu (black bars) was determined as detailed in Additional file 1:
Table S1. Shown are mean values of 4 independent experiments, standard error bars and P values. The square brackets in the figure indicate a
statistically significant difference between plus-and minus-strand transcripts calculated with a Mann–Whitney Rank Sum Test (p = 0.001 and
p= 0.002 for the Mo-T and BJAB-Gu cell lines respectively). C,D. Temporal analysis of HTLV-2 expression. A confluent culture of BJAB-Gu cells was
diluted to 25,000 cells/ml and aliquots were harvested every 24 h over a 96-h period. Shown are NCN of the sum of all (plus and minus strand)
viral transcripts at each time point (C) and SCN of individual mRNAs (D). The grey box in the figure (panel D), highlights the switch in the pattern
of expression from early to late transcripts.
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transcript were all expressed at lower levels. These data
are consistent with a previous study by Li et al. [14].
A recent study on the intracellular distribution of
HTLV-1 mRNAs indicated that the plus-strand tran-
scripts showed similar partition in the nucleus and cyto-
plasm, while the minus-strand mRNAs were over 10-fold
more abundant in the nucleus, suggesting that they may
play a role as a non-coding RNAs [10]. To test whetherthis is the case for HTLV-2, we analyzed the nucleo-
cytoplasmic distribution of plus- and minus-strand
HTLV-2 mRNAs. Results obtained in the Mo-T and
BJAB-Gu infected cell lines showed that all the plus-
strand mRNAs were equally distributed in the nucleus
and cytoplasm, while the minus-strand APH-2 mRNA
[15] was about 10-fold or 4-fold higher (Mo-T and BJAB-
Gu cell lines, respectively) in the nucleus (Figure 3B;
Mann–Whitney Rank Sum Test; p = 0.001 and p = 0.002
Figure 4 Temporal analysis of HTLV-2 expression in PBMCs from infected patients. Normalized copy number (NCN) and Scaled Copy
Numbers (SCN) were calculated as described in the text. The housekeeping gene used for the normalization was 18S rRNA and the resulted NCN
was multiplied for 107. A. NCN of the sum of all viral mRNAs (plus- and minus- strands) viral mRNAs in PBMCs from infected patients in a 48-h
time course of culture in vitro. PBMCs were cultured and harvested for total RNA at the indicated time points. B. NCN of the individual mRNAs in
HTLV-2-infected patients at time 0 (grey bars) and after 21 (patient A) or 24 (patients B and C) hours of culture (black bars). C. SCN of individual
mRNAs are plotted over a 48-h time period. The grey box in the figure, highlights the switch in the pattern of expression from early to late
transcripts.
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finding is reminiscent of cell lines chronically infected
with HTLV-1 [10].
We next investigated whether, in analogy to HTLV-1
[11], HTLV-2 is characterized by an early/late temporal
pattern of expression. To test this possibility in an
in vitro model, we induced HTLV-2 expression in BJAB-
Gu cells by diluting to 25,000 cells/ml starting from a
confluent culture and measured transcript levels over
96 h by qRT-PCR. As indicated in Figure 3C, this
treatment results in an overall upregulation of viral ex-
pression. To ensure that the pattern of viral expression
was not affected by cell death, we tested cell viability
by trypan blue exclusion at each time point and found
that cell death did not exceed 4% for up to 96 h of
culture. The amount of p19 released by the BJAB-Gu
cells was below the threshold of detection by ELISA at
0 and 24 h and rose to 62 pg/ml at 48 h, 121 pg/ml
at 72 h, and 169 pg/ml at 96 h.
To better visualize the timing of expression of individ-
ual mRNAs, we calculated the scaled copy number
(SCN) by dividing the normalized copy number (NCN)
of each transcript at each time point by the maximum
NCN measured for that mRNA during the experiment.
Results showed 2-phase kinetics with the expression of
tax/rex(1-2-3), p28/tRex(1-B) and 1-2-B preceding that
of gag/pol, env and p28/trex(1–3) mRNAs (Figure 3D), a
finding that is consistent with the key role of Tax and
Rex as master regulatory proteins driving expression of
the other viral genes.
Temporal analysis of HTLV-2 expression in PBMCs from
infected patients
We next used qRT-PCR to investigate HTLV-2 expres-
sion kinetics in PBMCs obtained from 3 HTLV-2B-
infected patients; these patients had similar proviral
loads and were HTLV-1- and HIV-1-negative (Add-
itional file 2: Table S2). All of the recruited patients gave
informed consent, according to the Italian laws and the
Declaration of Helsinki. The study was approved by the
institutional ethics committees of all participating insti-
tutions. As described for HTLV-1 [10], a sharp upregula-
tion of HTLV-2 transcripts was observed upon culture
of the PBMCs in all the examined patients (Figure 4A).
Before in vitro culture only gag/pol, APH2 and tax/rex
(1-2-3) were detected in all patients; p28/trex(1–3) was
detected only in patient A (Figure 4B, grey bars). Upon
in vitro culture the expression of all transcripts was
sharply upregulated (Figure 4B, black bars); however, pa-
tient C exhibited a marked downregulation of APH-2.
Following reactivation, gag/pol was the most abundant
transcript. Tax/rex(1-2-3), p28/trex(1–3), APH-2, and in
patients A and B, 1-2-B were also readily detected, while
the other transcripts were expressed at much lowerlevels. Consistent with the fact that the patients were
infected with HTLV-2 subtype B, env(1-2iso) was effi-
ciently detected, while env(1–2) was undetectable. Pa-
tient C did not express p28/trex(1-B) or (1-2-B). p11/p10
(1-2-A) was below the threshold of detection in all
patients. The tax/rex over p28/trex(1–3) ratio ranged be-
tween 0.9 and 7.6 (depending on the time point) in pa-
tient A, and was even more skewed in favor of p28/trex
(1–3) in patient B (ratios between 0.04 and 0.37, depend-
ing on the time point).
SCN calculations (Figure 4C) indicated a two-phase
kinetics of HTLV-2 gene expression in patients A and B,
with an early sharp rise in tax/rex(1-2-3) expression fol-
lowed by expression of all other genes. Patient B also
expressed p28/trex(1-B) as an early transcript, although
it its expression levels were lower by about 3 orders of
magnitude compared to the p28/tRex(1–3) (Figure 4B).
The expression pattern of patients A and B is similar
to that of the BJAB-Gu cell line (Figure 3D) and suggests
an early/late switch in the pattern of viral expression.
While plus-strand transcripts showed an overall com-
mon pattern of expression in two patients and in the
BJAB-Gu cell line, the temporal expression of APH-2
appeared to be highly variable, at least in the restricted
number of samples examined. Further studies carried
out on larger cohorts of samples should be performed,
to test the possible correlation of different APH-2 ex-
pression patterns with virus load and patient status. In
this regard, a recent study showed that both Tax and
APH-2 mRNA levels correlate with proviral load; inter-
estingly, no correlation was found between APH-2 levels
and the number of lymphocytes in the patients, suggest-
ing that, in contrast to HBZ, APH-2 does not promote
cell proliferation [16].
Although the temporal pattern of HTLV-2 expression
was reminiscent of that of HTLV-1, it is noteworthy that
the most abundant HTLV-2 mRNA encoding p28 and
tRex (i.e. mRNA1-3) was expressed from a “late” tran-
script, while HTLV-1 p21Rex was expressed as an early
transcript in most patients examined in a previous study
[10].
Taken together with previous analyses of HTLV-1
expression, the present study suggests a converging
expression strategy of the two viruses characterized by
2-phase expression kinetics of viral mRNAs and by
marked nuclear localization of minus-strand transcripts.
Our results also highlight the following differences be-
tween the 2 viruses: (i) the relative expression of the
tax/rex mRNA compared to the mRNAs coding for
potential inhibitors of Tax (p30Tof and p28) and Rex
[(p21Rex and p28/tRex(1–3)] is skewed toward tax/rex
in HTLV-1 and towards the inhibitors in HTLV-2; (ii)
the p28/trex mRNA was expressed as a “late” tran-
script in HTLV-2 while mRNAs for HTLV-1 orthologs
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patients examined, suggesting interesting differences in
the fine-tuning of Rex function between the two viruses.
Nevertheless, it is appropriate to be cautious in the in-
terpretation of these data, since only three patients were
examined. This limitation was due to the fact that the
kinetics analysis required (i) large numbers of PBMC,
(ii) a high proviral load, and (iii) no coinfection with
HIV or HTLV-1, which severely limited the number of
samples suitable for this analysis.
Future studies should be aimed at further investigating
the functions of these regulatory proteins in HTLV-1
and HTLV-2 and at understanding how they may con-
tribute to the different pathobiology of the two viruses.
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